New York started distributing what will amount to billions in opioid settlement funds nearly three years ago, pouring money ...
Directing a portion of these settlement funds to support social equity cannabis business operators is a promising strategy. This approach can help economic growth in communities disproportionately ...
Baltimore was smart to sue opioid makers and distributors, but will it be as wise in deciding how the funds are used?
The three largest U.S. drug distributors have agreed to pay $300 million to resolve claims by health insurers and benefit ...
After opting out of Teva’s $4.25 billion national opioid settlement last year, the city of Baltimore has secured its own payout through a settlement deal worth $80 million. Teva will make an ...
Pitkin County and the city of Aspen are using funds from opioid-related ... $787 million from settlements with over 11 companies: Kroger, Johnson & Johnson, CVS, Walgreens, McKinsey & Company ...
Sept 9 (Reuters) - When it comes to calling dibs on $2.1 billion set aside for lawyers who contributed to settlements with nine major opioids defendants, the plaintiffs' lawyers in charge of the ...
The city of St. Petersburg, Florida, is allocating $1 million from an opioid settlement to nonprofit organizations working to address the opioid crisis through treatment and recovery support services.
Baltimore Mayor Brandon Scott on Monday announced the city has reached an $80 million settlement with an opioid manufacturer. This is the fourth settlement reached with a drug maker, blaming those ...
BALTIMORE — The City of Baltimore has reached an $80 million settlement with Teva Pharmaceuticals, one of the defendants in the city’s ongoing lawsuit against drug manufacturers and distributors ...
The three largest U.S. drug distributors have agreed to pay $300 million to resolve claims by health insurers and benefit ...
The settlement brings the total amount the city has won from opioid companies to more than $322 million, Mayor Brandon M. Scott announced. Baltimore’s lawsuit against the remaining companies is ...